Compositions and methods for treating ocular edema, neovascularization and related diseases
AssigneeAerpio Pharmaceuticals, Inc.
InventorsKevin Gene PETERS, Robert Shalwitz
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for the treatment of diseases or conditions of the eye, especially retinopathies, ocular edema and ocular neovascularization. Non-limiting examples of these diseases or conditions include diabetic macular edema, age-related macular degeneration (wet form), choroidal neovascularization, diabetic retinopathy, retinal vein occlusion (central or branch), ocular trauma, surgery induced edema, surgery induced neovascularization, cystoid macular edema, ocular ischemia, uveitis, and the like.
Claims22
1-20. (canceled)
A method of treating an ocular condition in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of a pharmaceutical composition, wherein the pharmaceutical composition comprises a compound of the formula:
- or a pharmaceutically-acceptable salt thereof,
- wherein the administering is by intravitreal injection.
A method of treating an ocular condition in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of a pharmaceutical composition, wherein the pharmaceutical composition comprises a compound of the formula:
- or a pharmaceutically-acceptable salt thereof,
- wherein the administering is by subconjunctival injection.
A method of treating an ocular condition in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of a pharmaceutical implant, wherein the pharmaceutical implant comprises a compound of the formula:
- or a pharmaceutically-acceptable salt thereof,
Dependencies are inferred from the claim text.